期刊文献+

免疫介导型再生障碍性贫血小鼠间充质干细胞成骨及成脂潜能改变 被引量:5

The Potential Alteration of Their Osteogenesis and Adipocyte Differentiation in Bone Marrow Mesenchymal Stem Cells from Mice with Immune-mediated Aplastic Anemia
下载PDF
导出
摘要 [目的]探讨免疫介导型再生障碍性贫血小鼠间充质干细胞(msenchymal stem cell,MSC)向成骨及成脂肪细胞分化潜能的改变。[方法]采用免疫介导法进行再障造模,Babl/c小鼠经60Co射线亚致死剂量照射后,自尾静脉输入DBA/2小鼠的淋巴细胞建立免疫介导型再生障碍性贫血小鼠模型;造模15天后进行再生障碍性贫血小鼠骨髓间充质干细胞培养,并检测骨髓成纤维细胞集落形成单位(CFU-F)数量变化,观察模型小鼠骨髓病理改变;茜素红和油红O分别检测模型小鼠MSC钙结节数和脂肪细胞形成率。[结果]再障模型小鼠CFU-F数明显减少;骨髓病理切片显示,造血组织减少,并脂肪化;再障小鼠MSC钙结节数量减少,脂肪细胞分化率显著增加。[结论]免疫介导再生障碍性贫血小鼠MSC成骨潜能减弱,成脂潜能明显增强。 [Objective]To explore the potential alteration of their osteogenesis and adipocyte differentiation in bone marrow mesenchymal stems cells from mice with immune-mediated aplastic anemia.[Methods]Balb/c mice model of immune-mediated aplastic anemia was established by radiation with sublethal dose of 60Co following the intravenously infusion lymphocytes of DAB/2 mice.The culture of the MSC and CFU-F and pathological examination of bone marrow were carried out 15 days later.The amount of calcium node and the frequency of adipocyte differentiation were evaluated respectively by alizarin red and oil red O.[Result]The number of CFU-F and the number of calcium node in model mice decreased more greatly than normal mice,but the ferenqucy of adipocyte differentiation was more increased greatly in model mice than normal mice;the pathological examination showed in the model mice,the hematopoietic structure was destroyed and filled with abundant adipocyte.[Conclusion]The potention of osteogenesis and adipocyte differentiation was altered in the mice with immune-mediated aplastic anemia.
出处 《浙江中医药大学学报》 CAS 2009年第5期652-654,共3页 Journal of Zhejiang Chinese Medical University
基金 国家自然科学基金(No:30271597) 浙江省自然科学基金(No:Y207728) 浙江省中医药管理局(No:2008YA005)~~
关键词 再生障碍性贫血 骨髓间充质干细胞 成骨潜能 成脂潜能 aplastic anemia mesenchymal stem cell osteogenesis potential adipogenic potential
  • 相关文献

参考文献4

二级参考文献23

  • 1Jacobs P. Bone marrow failure: pathophysiology and management. Dis Mot 1995;41(4) :201--289.
  • 2Nissen C, Wodnar-Filipowicz A, Slanicka Krieger MS, et al.Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anemia and its association with relapse. Eur J Haematol 1995; 55 (4) :255--261.
  • 3储榆林.再生障碍性贫血[A].张之南 杨天楹 郝玉书主编.血液病学[C].北京:人民卫生出版社,2003.618-634.
  • 4Koc ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant, 2001; 27:235 -239.
  • 5Reyes M, Lund T, Lenvik T, et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells.Blood, 2001; 98:2615-2625.
  • 6Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol, 1998,176:57-66.
  • 7Noort WA, Kruisselbrind AB, in't-Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 + cells in NOD/SCID mice. Exp Hematol, 2002; 30:870 - 878.
  • 8in't-Anker PS, Noort WA, Kruisselbrink AB, et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34 + cells in NOD/SCID mice. Exp Hematol, 2003; 31:881 -889.
  • 9Lee ST, Jang JH, Cheong JW, et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002; 118:1128 - 1131.
  • 10Zhao RC, Liao I, Han Q. Mechanisms and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med, 2004;143:284 -291.

共引文献41

同被引文献32

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部